MedPage Today

For IBD, No Cardiovascular Risk Difference Between JAK, TNF Inhibitors

ORLANDO -- Major cardiovascular event risk in patients with inflammatory bowel disease (IBD) was no greater with Janus kinase (JAK) inhibitors than with tumor necrosis factor (TNF) inhibitors, ...
来自MSN

For IBD, No Cardiovascular Risk Difference Between JAK, TNF Inhibitors

ORLANDO -- Major cardiovascular event risk in patients with inflammatory bowel disease (IBD) was no greater with Janus kinase (JAK) inhibitors than with tumor necrosis factor (TNF) inhibitors, ...